Performance and Robustness of the Monte Carlo Importance Sampling Algorithm Using Parallelized S-ADAPT for Basic and Complex Mechanistic Models

The Monte Carlo Parametric Expectation Maximization (MC-PEM) algorithm can approximate the true log-likelihood as precisely as needed and is efficiently parallelizable. Our objectives were to evaluate an importance sampling version of the MC-PEM algorithm for mechanistic models and to qualify the de...

Full description

Saved in:
Bibliographic Details
Published inThe AAPS journal Vol. 13; no. 2; pp. 212 - 226
Main Authors Bulitta, Jurgen B., Landersdorfer, Cornelia B.
Format Journal Article
LanguageEnglish
Published Boston Springer US 01.06.2011
Subjects
Online AccessGet full text
ISSN1550-7416
1550-7416
DOI10.1208/s12248-011-9258-9

Cover

Abstract The Monte Carlo Parametric Expectation Maximization (MC-PEM) algorithm can approximate the true log-likelihood as precisely as needed and is efficiently parallelizable. Our objectives were to evaluate an importance sampling version of the MC-PEM algorithm for mechanistic models and to qualify the default estimation settings in SADAPT-TRAN. We assessed bias, imprecision and robustness of this algorithm in S-ADAPT for mechanistic models with up to 45 simultaneously estimated structural parameters, 14 differential equations, and 10 dependent variables (one drug concentration and nine pharmacodynamic effects). Simpler models comprising 15 parameters were estimated using three of the ten dependent variables. We set initial estimates to 0.1 or 10 times the true value and evaluated 30 bootstrap replicates with frequent or sparse sampling. Datasets comprised three dose levels with 16 subjects each. For simultaneous estimation of the full model, the ratio of estimated to true values for structural model parameters (median [5–95% percentile] over 45 parameters) was 1.01 [0.94–1.13] for means and 0.99 [0.68–1.39] for between-subject variances for frequent sampling and 1.02 [0.81–1.47] for means and 1.02 [0.47–2.56] for variances for sparse sampling. Imprecision was ≤25% for 43 of 45 means for frequent sampling. Bias and imprecision was well comparable for the full and simpler models. Parallelized estimation was 23-fold (6.9-fold) faster using 48 threads (eight threads) relative to one thread. The MC-PEM algorithm was robust and provided unbiased and adequately precise means and variances during simultaneous estimation of complex, mechanistic models in a 45 dimensional parameter space with rich or sparse data using poor initial estimates.
AbstractList The Monte Carlo Parametric Expectation Maximization (MC-PEM) algorithm can approximate the true log-likelihood as precisely as needed and is efficiently parallelizable. Our objectives were to evaluate an importance sampling version of the MC-PEM algorithm for mechanistic models and to qualify the default estimation settings in SADAPT-TRAN. We assessed bias, imprecision and robustness of this algorithm in S-ADAPT for mechanistic models with up to 45 simultaneously estimated structural parameters, 14 differential equations, and 10 dependent variables (one drug concentration and nine pharmacodynamic effects). Simpler models comprising 15 parameters were estimated using three of the ten dependent variables. We set initial estimates to 0.1 or 10 times the true value and evaluated 30 bootstrap replicates with frequent or sparse sampling. Datasets comprised three dose levels with 16 subjects each. For simultaneous estimation of the full model, the ratio of estimated to true values for structural model parameters (median [5-95% percentile] over 45 parameters) was 1.01 [0.94-1.13] for means and 0.99 [0.68-1.39] for between-subject variances for frequent sampling and 1.02 [0.81-1.47] for means and 1.02 [0.47-2.56] for variances for sparse sampling. Imprecision was ≤25% for 43 of 45 means for frequent sampling. Bias and imprecision was well comparable for the full and simpler models. Parallelized estimation was 23-fold (6.9-fold) faster using 48 threads (eight threads) relative to one thread. The MC-PEM algorithm was robust and provided unbiased and adequately precise means and variances during simultaneous estimation of complex, mechanistic models in a 45 dimensional parameter space with rich or sparse data using poor initial estimates.
The Monte Carlo Parametric Expectation Maximization (MC-PEM) algorithm can approximate the true log-likelihood as precisely as needed and is efficiently parallelizable. Our objectives were to evaluate an importance sampling version of the MC-PEM algorithm for mechanistic models and to qualify the default estimation settings in SADAPT-TRAN. We assessed bias, imprecision and robustness of this algorithm in S-ADAPT for mechanistic models with up to 45 simultaneously estimated structural parameters, 14 differential equations, and 10 dependent variables (one drug concentration and nine pharmacodynamic effects). Simpler models comprising 15 parameters were estimated using three of the ten dependent variables. We set initial estimates to 0.1 or 10 times the true value and evaluated 30 bootstrap replicates with frequent or sparse sampling. Datasets comprised three dose levels with 16 subjects each. For simultaneous estimation of the full model, the ratio of estimated to true values for structural model parameters (median [5-95% percentile] over 45 parameters) was 1.01 [0.94-1.13] for means and 0.99 [0.68-1.39] for between-subject variances for frequent sampling and 1.02 [0.81-1.47] for means and 1.02 [0.47-2.56] for variances for sparse sampling. Imprecision was ≤25% for 43 of 45 means for frequent sampling. Bias and imprecision was well comparable for the full and simpler models. Parallelized estimation was 23-fold (6.9-fold) faster using 48 threads (eight threads) relative to one thread. The MC-PEM algorithm was robust and provided unbiased and adequately precise means and variances during simultaneous estimation of complex, mechanistic models in a 45 dimensional parameter space with rich or sparse data using poor initial estimates.The Monte Carlo Parametric Expectation Maximization (MC-PEM) algorithm can approximate the true log-likelihood as precisely as needed and is efficiently parallelizable. Our objectives were to evaluate an importance sampling version of the MC-PEM algorithm for mechanistic models and to qualify the default estimation settings in SADAPT-TRAN. We assessed bias, imprecision and robustness of this algorithm in S-ADAPT for mechanistic models with up to 45 simultaneously estimated structural parameters, 14 differential equations, and 10 dependent variables (one drug concentration and nine pharmacodynamic effects). Simpler models comprising 15 parameters were estimated using three of the ten dependent variables. We set initial estimates to 0.1 or 10 times the true value and evaluated 30 bootstrap replicates with frequent or sparse sampling. Datasets comprised three dose levels with 16 subjects each. For simultaneous estimation of the full model, the ratio of estimated to true values for structural model parameters (median [5-95% percentile] over 45 parameters) was 1.01 [0.94-1.13] for means and 0.99 [0.68-1.39] for between-subject variances for frequent sampling and 1.02 [0.81-1.47] for means and 1.02 [0.47-2.56] for variances for sparse sampling. Imprecision was ≤25% for 43 of 45 means for frequent sampling. Bias and imprecision was well comparable for the full and simpler models. Parallelized estimation was 23-fold (6.9-fold) faster using 48 threads (eight threads) relative to one thread. The MC-PEM algorithm was robust and provided unbiased and adequately precise means and variances during simultaneous estimation of complex, mechanistic models in a 45 dimensional parameter space with rich or sparse data using poor initial estimates.
Author Bulitta, Jurgen B.
Landersdorfer, Cornelia B.
Author_xml – sequence: 1
  givenname: Jurgen B.
  surname: Bulitta
  fullname: Bulitta, Jurgen B.
  email: j@bulitta.com
  organization: Ordway Research Institute, Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, State University of New York at Buffalo
– sequence: 2
  givenname: Cornelia B.
  surname: Landersdorfer
  fullname: Landersdorfer, Cornelia B.
  organization: Ordway Research Institute, Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, State University of New York at Buffalo
BackLink https://www.ncbi.nlm.nih.gov/pubmed/21374103$$D View this record in MEDLINE/PubMed
BookMark eNqNkd9uFCEUxompse3qA3hjuPNqFBhmhrkxWdd_TbpxY9trwjBnd2kYGIFR60v4yrLdtaleNF4Bh-87H-fHKTpy3gFCzyl5RRkRryNljIuCUFq0rBJF-wid0KoiRcNpfXRvf4xOY7wmpGQlpU_QMaNlLpPyBP1aQVj7MCinASvX4y--m2JyECP2a5y2gJfeJcALFazHZ8PoQ7oVX6hhtMZt8NxufDBpO-CruDuvVFDWgjU_occXxfzdfHWJcwZ-q6LRtyELn73wAy9Bb5UzMeX60vdg41P0eK1shGeHdYauPry_XHwqzj9_PFvMzwvNOU1FU3IOfd8RCgBNTTVwaGnJqKq7mhNVkZ7lQkMo6zOpuheqE7UQrRBdC6QpZ4jt-05uVDff84PlGMygwo2kRO7oyj1dmenKHV3ZZtObvWmcugF6DS7lUe-MXhn5940zW7nx32RJRNVk_DP08tAg-K8TxCQHEzVYqxz4KUpR80bwirCsfHE_6i7jz89lQbMX6OBjDLCW2iSVjN8lG_vgFPQf5_9MfsAVs9ZtIMhrPwWXf-gB0285t83W
CitedBy_id crossref_primary_10_1208_s12248_015_9764_2
crossref_primary_10_1016_j_jconrel_2016_02_042
crossref_primary_10_1128_AAC_01268_17
crossref_primary_10_1208_s12248_017_0138_9
crossref_primary_10_1007_s10928_014_9359_z
crossref_primary_10_1093_jac_dku567
crossref_primary_10_1128_AAC_00259_15
crossref_primary_10_1093_cid_cit334
crossref_primary_10_1128_AAC_01741_13
crossref_primary_10_1128_AAC_01354_12
crossref_primary_10_1016_j_xphs_2023_10_029
crossref_primary_10_1128_AAC_01679_19
crossref_primary_10_1371_journal_pcbi_1004782
crossref_primary_10_1177_2050312118813283
crossref_primary_10_1128_AAC_00028_18
crossref_primary_10_1208_s12248_013_9524_0
crossref_primary_10_1128_aac_01393_23
crossref_primary_10_1002_jps_24412
crossref_primary_10_1128_AAC_02642_16
crossref_primary_10_1128_AAC_00092_13
crossref_primary_10_4155_bio_2018_0078
crossref_primary_10_1128_AAC_01150_18
crossref_primary_10_1155_2014_402126
crossref_primary_10_1128_AAC_00722_17
crossref_primary_10_1128_AAC_02176_18
crossref_primary_10_1007_s11095_019_2732_2
crossref_primary_10_1016_j_ejps_2018_05_017
crossref_primary_10_1128_AAC_02053_17
crossref_primary_10_1016_j_aquaculture_2023_740222
crossref_primary_10_1128_AAC_01934_16
crossref_primary_10_1128_AAC_00937_12
crossref_primary_10_3390_molecules22091488
crossref_primary_10_1007_s11095_023_03472_6
crossref_primary_10_1128_aac_01394_23
crossref_primary_10_1093_jac_dkv031
crossref_primary_10_1128_AAC_01965_17
crossref_primary_10_1128_aac_00414_23
crossref_primary_10_1007_s10856_015_5444_0
crossref_primary_10_1016_j_ejps_2017_06_008
crossref_primary_10_1128_AAC_00078_18
crossref_primary_10_3390_microorganisms9020307
crossref_primary_10_1093_cid_ciae093
crossref_primary_10_1021_acsptsci_0c00045
crossref_primary_10_1093_jac_dks201
crossref_primary_10_1007_s40262_012_0012_y
crossref_primary_10_1128_AAC_02377_15
crossref_primary_10_1021_acs_molpharmaceut_5b00749
crossref_primary_10_1093_jac_dkac124
crossref_primary_10_1128_AAC_01011_16
crossref_primary_10_1128_AAC_03510_14
crossref_primary_10_1016_j_ejps_2018_07_054
crossref_primary_10_1093_jac_dkw293
crossref_primary_10_1128_AAC_01885_13
crossref_primary_10_1128_AAC_00211_17
crossref_primary_10_1016_j_ejps_2015_07_017
crossref_primary_10_1128_AAC_04379_14
crossref_primary_10_1016_j_ejps_2017_10_018
crossref_primary_10_1016_j_actbio_2023_12_002
crossref_primary_10_1002_psp4_12714
crossref_primary_10_1093_jac_dkx409
crossref_primary_10_1093_jac_dkw153
crossref_primary_10_3390_pharmaceutics11070323
crossref_primary_10_1111_jvp_12091
crossref_primary_10_1128_AAC_02307_18
crossref_primary_10_1016_j_ijantimicag_2025_107488
crossref_primary_10_1093_jac_dkw355
crossref_primary_10_1007_s40262_016_0430_3
crossref_primary_10_1016_j_ijpharm_2022_121624
crossref_primary_10_1128_aac_00197_23
crossref_primary_10_1128_AAC_00967_18
crossref_primary_10_1128_aac_01400_23
crossref_primary_10_1128_AAC_02055_17
crossref_primary_10_1128_aac_01081_23
crossref_primary_10_1093_cid_ciz067
crossref_primary_10_1128_AAC_00952_16
crossref_primary_10_1007_s10928_017_9554_9
crossref_primary_10_1128_AAC_04099_14
crossref_primary_10_1016_j_cmi_2020_02_004
crossref_primary_10_1128_AAC_02927_15
crossref_primary_10_1128_AAC_05453_11
crossref_primary_10_1016_j_cmi_2020_04_039
crossref_primary_10_1128_aac_01399_23
crossref_primary_10_3390_pharmaceutics11060286
crossref_primary_10_1128_AAC_00973_17
Cites_doi 10.2307/2684170
10.1124/jpet.110.167304
10.1007/s00280-008-0827-2
10.1023/A:1020707208521
10.1023/B:JOPA.0000042738.06821.61
10.2307/2533054
10.2165/11318090-000000000-00000
10.1051/ps:2004007
10.1038/clpt.2009.87
10.2165/00003088-200645040-00003
10.1038/sj.clpt.6100476
10.1016/j.csda.2007.03.008
10.1023/A:1012299115260
10.1124/jpet.108.137372
10.1002/(SICI)1097-0258(19970615)16:11<1241::AID-SIM527>3.0.CO;2-C
10.1208/ps020332
10.1214/aos/1018031103
10.2165/00003088-199834010-00003
10.1214/aos/1176346060
10.1023/A:1011517718990
10.1023/A:1025542026488
10.1038/clpt.2008.52
10.1016/0096-3003(91)90077-Z
10.1137/0904010
10.1016/j.toxicon.2008.08.013
10.1208/aapsj0901007
10.2307/2286284
10.1007/BF01061030
10.1081/BIP-200040824
10.1124/jpet.108.137703
10.1007/s10928-009-9126-8
10.1128/AAC.00881-09
10.1007/BF01060053
10.1124/jpet.108.144766
10.1023/A:1023573429626
10.1016/0010-468X(79)90025-4
10.1007/s11095-005-5642-4
10.3109/03602538409015066
10.1208/s12248-007-9006-3
10.1007/s00280-009-1023-8
10.1128/AAC.00489-08
10.1007/s00280-010-1393-y
10.1111/j.2517-6161.1977.tb01600.x
ContentType Journal Article
Copyright American Association of Pharmaceutical Scientists 2011
Copyright_xml – notice: American Association of Pharmaceutical Scientists 2011
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ADTOC
UNPAY
DOI 10.1208/s12248-011-9258-9
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
Unpaywall for CDI: Periodical Content
Unpaywall
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: UNPAY
  name: Unpaywall
  url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1550-7416
EndPage 226
ExternalDocumentID 10.1208/s12248-011-9258-9
PMC3085700
21374103
10_1208_s12248_011_9258_9
Genre Journal Article
GroupedDBID ---
-56
-5G
-BR
-EM
-Y2
-~C
.86
.VR
06C
06D
0R~
123
1N0
203
23M
29~
2J2
2JN
2JY
2KG
2KM
2LR
2VQ
2~H
30V
4.4
406
408
40D
40E
53G
67N
6J9
6NX
875
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AAKDD
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABJNI
ABJOX
ABKCH
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABSXP
ABTEG
ABTHY
ABTKH
ABTMW
ABULA
ABWNU
ABXPI
ACAOD
ACDTI
ACGFS
ACHSB
ACHXU
ACKNC
ACMDZ
ACMJI
ACMLO
ACOKC
ACOMO
ACPIV
ACREN
ACSNA
ACZOJ
ADBBV
ADHIR
ADINQ
ADKNI
ADKPE
ADQRH
ADRFC
ADURQ
ADYFF
ADYOE
ADZKW
AEBTG
AEFQL
AEGAL
AEGNC
AEGXH
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFGCZ
AFLOW
AFQWF
AFWTZ
AFYQB
AFZKB
AGAYW
AGDGC
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWZB
AGYKE
AHAVH
AHBYD
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMTXH
AMXSW
AMYLF
AOCGG
AOIJS
ARMRJ
AXYYD
B-.
BA0
BAWUL
BDATZ
BGNMA
C1A
CAG
COF
CS3
CSCUP
DDRTE
DIK
DNIVK
DPUIP
E3Z
EBD
EBLON
EBS
EIOEI
EJD
EMOBN
EN4
ESBYG
F5P
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GX1
H13
HG6
HH5
HMJXF
HRMNR
HYE
HZ~
IAO
IEA
IHR
IJ-
IKXTQ
IWAJR
IXC
IXD
I~X
I~Z
J-C
J0Z
JBSCW
JZLTJ
KOV
KPH
LGEZI
LLZTM
LOTEE
M4Y
MA-
MK0
NADUK
NPVJJ
NQJWS
NU0
NXXTH
O9-
O93
O9I
O9J
OK1
P6G
PF0
PT4
PT5
QOR
QOS
R89
R9I
ROL
RPM
RPX
RSV
S16
S1Z
S27
S3A
S3B
SAP
SBL
SHX
SISQX
SJYHP
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZN
T13
TSG
TSV
TUC
U2A
U9L
UG4
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W48
WK8
XSB
YLTOR
Z45
Z7U
Z7V
Z7W
Z7X
Z81
Z83
Z87
ZMTXR
ZOVNA
~A9
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ABRTQ
ACSTC
AEZWR
AFDZB
AFHIU
AFOHR
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ADTOC
UNPAY
ID FETCH-LOGICAL-c441t-7344eddb01eee761ce4e91321a6b640a50d2e917012d2086d8ab8688988b9e073
IEDL.DBID U2A
ISSN 1550-7416
IngestDate Wed Oct 01 16:40:49 EDT 2025
Thu Aug 21 18:20:32 EDT 2025
Fri Sep 05 14:14:57 EDT 2025
Mon Jul 21 06:05:17 EDT 2025
Wed Oct 01 06:46:20 EDT 2025
Thu Apr 24 22:54:03 EDT 2025
Fri Feb 21 02:33:47 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords mechanistic population pharmacokinetic
Monte Carlo importance sampling
nonlinear mixed-effects modeling in S-ADAPT
pharmacodynamic modeling
parallel computing
Monte Carlo parametric expectation maximization (MC-PEM) algorithm
Language English
License http://www.springer.com/tdm
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c441t-7344eddb01eee761ce4e91321a6b640a50d2e917012d2086d8ab8688988b9e073
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://proxy.k.utb.cz/login?url=https://link.springer.com/content/pdf/10.1208/s12248-011-9258-9.pdf
PMID 21374103
PQID 864784502
PQPubID 23479
PageCount 15
ParticipantIDs unpaywall_primary_10_1208_s12248_011_9258_9
pubmedcentral_primary_oai_pubmedcentral_nih_gov_3085700
proquest_miscellaneous_864784502
pubmed_primary_21374103
crossref_citationtrail_10_1208_s12248_011_9258_9
crossref_primary_10_1208_s12248_011_9258_9
springer_journals_10_1208_s12248_011_9258_9
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2011-06-01
PublicationDateYYYYMMDD 2011-06-01
PublicationDate_xml – month: 06
  year: 2011
  text: 2011-06-01
  day: 01
PublicationDecade 2010
PublicationPlace Boston
PublicationPlace_xml – name: Boston
– name: United States
PublicationSubtitle An Official Journal of the American Association of Pharmaceutical Scientists
PublicationTitle The AAPS journal
PublicationTitleAbbrev AAPS J
PublicationTitleAlternate AAPS J
PublicationYear 2011
Publisher Springer US
Publisher_xml – name: Springer US
References Earp, Dubois, Molano, Pyszczynski, Keller, Almon (CR21) 2008; 326
Kuhn, Lavielle (CR53) 2004; 8
Petzold (CR50) 1983; 4
Landersdorfer, DuBois, Almon, Jusko (CR22) 2009; 328
Duffull, Kirkpatrick, Green, Holford (CR44) 2005; 15
Mager, Jusko (CR25) 2008; 83
Wu (CR6) 1983; 11
Schumitzky (CR10) 1991; 45
Xu, Eiseman, Egorin, D’Argenio (CR37) 2003; 30
Delyon, Lavielle, Moulines (CR52) 1999; 27
Beal, Sheiner, Boeckmann, Bauer (CR16) 2009
Friberg, Karlsson (CR30) 2003; 21
Plan, Maloney, Troconiz, Karlsson (CR46) 2009; 36
Ait-Oudhia, Scherrmann, Krzyzanski (CR23) 2010; 334
Sheiner, Beal (CR41) 1981; 9
Bulitta, Zhao, Arnold, Kessler, Daifuku, Pratt (CR32) 2009; 63
Fung, Tsou, Bulitta, Tran, Page, Soda (CR36) 2008; 10
Wiczling, Lowe, Pigeolet, Ludicke, Balser, Krzyzanski (CR33) 2009; 48
CR8
Beal (CR39) 2001; 28
Ng, Patnaik, Beeram, Lin, Takimoto (CR28) 2010
Tanos, Isbister, Lalloo, Kirkpatrick, Duffull (CR34) 2008; 52
Bauer, Guzy, Ng (CR4) 2007; 9
Smith, Gelfand (CR17) 1992; 46
Bulitta, Ly, Yang, Forrest, Jusko, Tsuji (CR26) 2009; 53
Jonsson, Wade, Karlsson (CR47) 2000; 2
Krzyzanski, Jusko (CR49) 2001; 28
Krzyzanski, Jusko (CR48) 1998; 26
Wajima, Isbister, Duffull (CR35) 2009; 86
Jonsson, Kjellsson, Karlsson (CR45) 2004; 31
Laird (CR11) 1978; 73
Bauer, Guzy, D’Argenio (CR18) 2003
CR19
D’Argenio, Schumitzky (CR14) 1979; 9
Sheiner, Beal (CR40) 1980; 8
CR15
CR13
Ng, Bai, Takimoto, Tang, Tolcher (CR29) 2009; 65
CR12
CR51
Bustad, Terziivanov, Leary, Port, Schumitzky, Jelliffe (CR7) 2006; 45
Jelliffe, Schumitzky, Bayard, Milman, Van Guilder, Wang (CR9) 1998; 34
Bulitta, Yang, Yohonn, Ly, Brown, D’Hondt (CR24) 2010; 54
Dempster, Laird, Rubin (CR1) 1977; 39
Steimer, Mallet, Golmard, Boisvieux (CR42) 1984; 15
Hooker, Ten Tije, Carducci, Weber, Garrett-Mayer, Gelderblom (CR31) 2008; 84
Schumitzky, D’Argenio (CR2) 1995
Wang, Schumitzky, D’Argenio (CR5) 2007; 51
CR20
Walker (CR3) 1996; 52
Ng, Joshi, Dedrick, Garovoy, Bauer (CR27) 2005; 22
Marathe, Peterson, Mager (CR38) 2008; 326
Roe (CR43) 1997; 16
A Schumitzky (9258_CR10) 1991; 45
L Xu (9258_CR37) 2003; 30
B Delyon (9258_CR52) 1999; 27
AFM Smith (9258_CR17) 1992; 46
RJ Bauer (9258_CR4) 2007; 9
9258_CR20
LE Friberg (9258_CR30) 2003; 21
C-FJ Wu (9258_CR6) 1983; 11
N Laird (9258_CR11) 1978; 73
DZ D’Argenio (9258_CR14) 1979; 9
S Jonsson (9258_CR45) 2004; 31
CM Ng (9258_CR27) 2005; 22
LR Petzold (9258_CR50) 1983; 4
9258_CR8
AC Hooker (9258_CR31) 2008; 84
P Wiczling (9258_CR33) 2009; 48
EL Plan (9258_CR46) 2009; 36
HL Fung (9258_CR36) 2008; 10
X Wang (9258_CR5) 2007; 51
A Schumitzky (9258_CR2) 1995
A Bustad (9258_CR7) 2006; 45
W Krzyzanski (9258_CR48) 1998; 26
DJ Roe (9258_CR43) 1997; 16
SL Beal (9258_CR16) 2009
JB Bulitta (9258_CR32) 2009; 63
AP Dempster (9258_CR1) 1977; 39
RJ Bauer (9258_CR18) 2003
W Krzyzanski (9258_CR49) 2001; 28
E Kuhn (9258_CR53) 2004; 8
PP Tanos (9258_CR34) 2008; 52
JB Bulitta (9258_CR24) 2010; 54
LB Sheiner (9258_CR40) 1980; 8
DE Mager (9258_CR25) 2008; 83
EN Jonsson (9258_CR47) 2000; 2
RW Jelliffe (9258_CR9) 1998; 34
JB Bulitta (9258_CR26) 2009; 53
CM Ng (9258_CR29) 2009; 65
SL Beal (9258_CR39) 2001; 28
SB Duffull (9258_CR44) 2005; 15
9258_CR51
CM Ng (9258_CR28) 2010
LB Sheiner (9258_CR41) 1981; 9
A Marathe (9258_CR38) 2008; 326
9258_CR19
JC Earp (9258_CR21) 2008; 326
S Ait-Oudhia (9258_CR23) 2010; 334
S Walker (9258_CR3) 1996; 52
9258_CR12
JL Steimer (9258_CR42) 1984; 15
T Wajima (9258_CR35) 2009; 86
9258_CR15
9258_CR13
CB Landersdorfer (9258_CR22) 2009; 328
20211900 - Antimicrob Agents Chemother. 2010 May;54(5):2051-62
15702605 - J Biopharm Stat. 2005;15(1):53-73
7229908 - J Pharmacokinet Biopharm. 1980 Dec;8(6):553-71
18852268 - Antimicrob Agents Chemother. 2009 Jan;53(1):46-56
19516255 - Clin Pharmacol Ther. 2009 Sep;86(3):290-8
18971370 - J Pharmacol Exp Ther. 2009 Feb;328(2):644-51
18446506 - AAPS J. 2008;10(1):56-69
14571691 - J Pharmacokinet Pharmacodyn. 2003 Jun;30(3):185-219
10485083 - J Pharmacokinet Biopharm. 1998 Dec;26(6):735-41
9474473 - Clin Pharmacokinet. 1998 Jan;34(1):57-77
6745083 - Drug Metab Rev. 1984;15(1-2):265-92
11253614 - J Pharmacokinet Pharmacodyn. 2001 Feb;28(1):57-78
11741248 - AAPS PharmSci. 2000;2(3):E32
20501635 - J Pharmacol Exp Ther. 2010 Sep 1;334(3):897-910
7334463 - J Pharmacokinet Biopharm. 1981 Oct;9(5):635-51
18460643 - J Pharmacol Exp Ther. 2008 Aug;326(2):555-62
19756256 - Comput Stat Data Anal. 2007 Aug 15;51(12):6614-6623
11768292 - J Pharmacokinet Pharmacodyn. 2001 Oct;28(5):481-504
1807753 - Proc Annu Symp Comput Appl Med Care. 1991;:922-4
18831981 - Toxicon. 2008 Dec 1;52(7):769-80
12889739 - Invest New Drugs. 2003 May;21(2):183-94
19468731 - Cancer Chemother Pharmacol. 2010 Jan;65(2):207-17
19902989 - Clin Pharmacokinet. 2009;48(12):817-26
761456 - Comput Programs Biomed. 1979 Mar;9(2):115-34
9194270 - Stat Med. 1997 Jun 15;16(11):1241-57; discussion 1257-62
16584284 - Clin Pharmacokinet. 2006;45(4):365-83
20614121 - Cancer Chemother Pharmacol. 2011 May;67(5):985-94
16028009 - Pharm Res. 2005 Jul;22(7):1088-100
15563005 - J Pharmacokinet Pharmacodyn. 2004 Aug;31(4):299-320
18388873 - Clin Pharmacol Ther. 2008 Jun;83(6):909-12
18791718 - Cancer Chemother Pharmacol. 2009 May;63(6):1049-63
18448865 - J Pharmacol Exp Ther. 2008 Aug;326(2):532-45
19653080 - J Pharmacokinet Pharmacodyn. 2009 Aug;36(4):353-66
18183036 - Clin Pharmacol Ther. 2008 Jul;84(1):111-8
17408237 - AAPS J. 2007;9(1):E60-83
References_xml – volume: 46
  start-page: 84
  year: 1992
  end-page: 88
  ident: CR17
  article-title: Bayesian statistics without tears: a sampling–resampling perspective
  publication-title: Am Stat
  doi: 10.2307/2684170
– volume: 334
  start-page: 897
  year: 2010
  end-page: 910
  ident: CR23
  article-title: Simultaneous pharmacokinetics/pharmacodynamics modeling of recombinant human erythropoietin upon multiple intravenous dosing in rats
  publication-title: J Pharmacol Exp Ther
  doi: 10.1124/jpet.110.167304
– volume: 63
  start-page: 1049
  year: 2009
  end-page: 63
  ident: CR32
  article-title: Mechanistic population pharmacokinetics of total and unbound paclitaxel for a new nanodroplet formulation Taxol in cancer patients
  publication-title: Cancer Chemother Pharmacol
  doi: 10.1007/s00280-008-0827-2
– volume: 26
  start-page: 735
  year: 1998
  end-page: 41
  ident: CR48
  article-title: Note: caution in use of empirical equations for pharmacodynamic indirect response models
  publication-title: J Pharmacokinet Biopharm
  doi: 10.1023/A:1020707208521
– start-page: 135
  year: 2003
  end-page: 63
  ident: CR18
  article-title: Monte Carlo parametric expectation maximization (MC-PEM) method for analyzing population pharmacokinetic/pharmacodynamic data
  publication-title: Advanced methods of pharmacokinetic and pharmacodynamic systems analysis
– volume: 31
  start-page: 299
  year: 2004
  end-page: 320
  ident: CR45
  article-title: Estimating bias in population parameters for some models for repeated measures ordinal data using NONMEM and NLMIXED
  publication-title: J Pharmacokinet Pharmacodyn
  doi: 10.1023/B:JOPA.0000042738.06821.61
– start-page: 145
  year: 1995
  end-page: 60
  ident: CR2
  article-title: EM algorithms and two-stage methods in pharmacokinetic population analysis
  publication-title: Advanced methods of pharmacokinetic and pharmacodynamic systems analysis
– volume: 52
  start-page: 934
  year: 1996
  end-page: 44
  ident: CR3
  article-title: An EM algorithm for nonlinear random effects models
  publication-title: Biometrics
  doi: 10.2307/2533054
– volume: 48
  start-page: 817
  year: 2009
  end-page: 26
  ident: CR33
  article-title: Population pharmacokinetic modelling of filgrastim in healthy adults following intravenous and subcutaneous administrations
  publication-title: Clin Pharmacokinet
  doi: 10.2165/11318090-000000000-00000
– ident: CR51
– ident: CR12
– volume: 8
  start-page: 115
  year: 2004
  end-page: 31
  ident: CR53
  article-title: Coupling a stochastic approximation version of EM with a MCMC procedure
  publication-title: ESAIM Probab Stat
  doi: 10.1051/ps:2004007
– volume: 86
  start-page: 290
  year: 2009
  end-page: 8
  ident: CR35
  article-title: A comprehensive model for the humoral coagulation network in humans
  publication-title: Clin Pharmacol Ther
  doi: 10.1038/clpt.2009.87
– volume: 45
  start-page: 365
  year: 2006
  end-page: 83
  ident: CR7
  article-title: Parametric and nonparametric population methods: their comparative performance in analysing a clinical dataset and two Monte Carlo simulation studies
  publication-title: Clin Pharmacokinet
  doi: 10.2165/00003088-200645040-00003
– ident: CR8
– volume: 84
  start-page: 111
  year: 2008
  end-page: 8
  ident: CR31
  article-title: Population pharmacokinetic model for docetaxel in patients with varying degrees of liver function: incorporating cytochrome P4503A activity measurements
  publication-title: Clin Pharmacol Ther
  doi: 10.1038/sj.clpt.6100476
– volume: 51
  start-page: 6614
  year: 2007
  end-page: 23
  ident: CR5
  article-title: Nonlinear random effects mixture models: maximum likelihood estimation via the EM algorithm
  publication-title: Comput Stat Data Anal
  doi: 10.1016/j.csda.2007.03.008
– volume: 28
  start-page: 481
  year: 2001
  end-page: 504
  ident: CR39
  article-title: Ways to fit a PK model with some data below the quantification limit
  publication-title: J Pharmacokinet Pharmacodyn
  doi: 10.1023/A:1012299115260
– ident: CR19
– ident: CR15
– volume: 326
  start-page: 532
  year: 2008
  end-page: 45
  ident: CR21
  article-title: Modeling corticosteroid effects in a rat model of rheumatoid arthritis I: mechanistic disease progression model for the time course of collagen-induced arthritis in Lewis rats
  publication-title: J Pharmacol Exp Ther
  doi: 10.1124/jpet.108.137372
– volume: 16
  start-page: 1241
  year: 1997
  end-page: 57
  ident: CR43
  article-title: Comparison of population pharmacokinetic modeling methods using simulated data: results from the Population Modeling Workgroup
  publication-title: Stat Med
  doi: 10.1002/(SICI)1097-0258(19970615)16:11<1241::AID-SIM527>3.0.CO;2-C
– volume: 2
  start-page: E32
  year: 2000
  ident: CR47
  article-title: Nonlinearity detection: advantages of nonlinear mixed-effects modeling
  publication-title: AAPS PharmSci
  doi: 10.1208/ps020332
– volume: 27
  start-page: 94
  year: 1999
  end-page: 128
  ident: CR52
  article-title: Convergence of a stochastic approximation version of the EM algorithm
  publication-title: Ann Stat
  doi: 10.1214/aos/1018031103
– volume: 34
  start-page: 57
  year: 1998
  end-page: 77
  ident: CR9
  article-title: Model-based, goal-oriented, individualised drug therapy. Linkage of population modelling, new ‘multiple model’ dosage design, Bayesian feedback and individualised target goals
  publication-title: Clin Pharmacokinet
  doi: 10.2165/00003088-199834010-00003
– volume: 11
  start-page: 95
  year: 1983
  end-page: 103
  ident: CR6
  article-title: On the convergence properties of the EM algorithm
  publication-title: Ann Stat
  doi: 10.1214/aos/1176346060
– year: 2010
  ident: CR28
  article-title: Mechanism-based pharmacokinetic/pharmacodynamic model for troxacitabine-induced neutropenia in cancer patients
  publication-title: Cancer Chemother Pharmacol
– volume: 28
  start-page: 57
  year: 2001
  end-page: 78
  ident: CR49
  article-title: Indirect pharmacodynamic models for responses with multicompartmental distribution or polyexponential disposition
  publication-title: J Pharmacokinet Pharmacodyn
  doi: 10.1023/A:1011517718990
– volume: 30
  start-page: 185
  year: 2003
  end-page: 219
  ident: CR37
  article-title: Physiologically-based pharmacokinetics and molecular pharmacodynamics of 17-(allylamino)-17-demethoxygeldanamycin and its active metabolite in tumor-bearing mice
  publication-title: J Pharmacokinet Pharmacodyn
  doi: 10.1023/A:1025542026488
– volume: 83
  start-page: 909
  year: 2008
  end-page: 12
  ident: CR25
  article-title: Development of translational pharmacokinetic–pharmacodynamic models
  publication-title: Clin Pharmacol Ther
  doi: 10.1038/clpt.2008.52
– volume: 45
  start-page: 143
  year: 1991
  end-page: 57
  ident: CR10
  article-title: Nonparametric EM algorithms for estimating prior distributions
  publication-title: Appl Math Comput
  doi: 10.1016/0096-3003(91)90077-Z
– volume: 4
  start-page: 136
  year: 1983
  end-page: 48
  ident: CR50
  article-title: Automatic selection of methods for solving stiff and nonstiff systems of ordinary diferential equations
  publication-title: Siam J Sci Stat Comput
  doi: 10.1137/0904010
– volume: 52
  start-page: 769
  year: 2008
  end-page: 80
  ident: CR34
  article-title: A model for venom-induced consumptive coagulopathy in snake bite
  publication-title: Toxicon
  doi: 10.1016/j.toxicon.2008.08.013
– volume: 9
  start-page: E60
  year: 2007
  end-page: 83
  ident: CR4
  article-title: A survey of population analysis methods and software for complex pharmacokinetic and pharmacodynamic models with examples
  publication-title: AAPS J
  doi: 10.1208/aapsj0901007
– volume: 73
  start-page: 805
  year: 1978
  end-page: 11
  ident: CR11
  article-title: Nonparametric maximum likelihood estimation of a mixing distribution
  publication-title: J Amer Stat Assn
  doi: 10.2307/2286284
– volume: 9
  start-page: 635
  year: 1981
  end-page: 51
  ident: CR41
  article-title: Evaluation of methods for estimating population pharmacokinetic parameters II. Biexponential model and experimental pharmacokinetic data
  publication-title: J Pharmacokinet Biopharm
  doi: 10.1007/BF01061030
– volume: 15
  start-page: 53
  year: 2005
  end-page: 73
  ident: CR44
  article-title: Analysis of population pharmacokinetic data using NONMEM and WinBUGS
  publication-title: J Biopharm Stat
  doi: 10.1081/BIP-200040824
– volume: 326
  start-page: 555
  year: 2008
  end-page: 62
  ident: CR38
  article-title: Integrated cellular bone homeostasis model for denosumab pharmacodynamics in multiple myeloma patients
  publication-title: J Pharmacol Exp Ther
  doi: 10.1124/jpet.108.137703
– volume: 36
  start-page: 353
  year: 2009
  end-page: 66
  ident: CR46
  article-title: Performance in population models for count data, part I: maximum likelihood approximations
  publication-title: J Pharmacokinet Pharmacodyn
  doi: 10.1007/s10928-009-9126-8
– volume: 54
  start-page: 2051
  year: 2010
  end-page: 62
  ident: CR24
  article-title: Attenuation of colistin bactericidal activity by high inoculum of characterized by a new mechanism-based population pharmacodynamic model
  publication-title: Antimicrob Agents Chemother
  doi: 10.1128/AAC.00881-09
– volume: 8
  start-page: 553
  year: 1980
  end-page: 71
  ident: CR40
  article-title: Evaluation of methods for estimating population pharmacokinetics parameters. I. Michaelis–Menten model: routine clinical pharmacokinetic data
  publication-title: J Pharmacokinet Biopharm
  doi: 10.1007/BF01060053
– volume: 328
  start-page: 644
  year: 2009
  end-page: 51
  ident: CR22
  article-title: Mechanism-based modeling of nutritional and leptin influences on growth in normal and type 2 diabetic rats
  publication-title: J Pharmacol Exp Ther
  doi: 10.1124/jpet.108.144766
– volume: 21
  start-page: 183
  year: 2003
  end-page: 94
  ident: CR30
  article-title: Mechanistic models for myelosuppression
  publication-title: Investig New Drugs
  doi: 10.1023/A:1023573429626
– ident: CR13
– volume: 9
  start-page: 115
  year: 1979
  end-page: 34
  ident: CR14
  article-title: A program package for simulation and parameter estimation in pharmacokinetic systems
  publication-title: Comput Programs Biomed
  doi: 10.1016/0010-468X(79)90025-4
– volume: 22
  start-page: 1088
  year: 2005
  end-page: 100
  ident: CR27
  article-title: Pharmacokinetic–pharmacodynamic efficacy analysis of efalizumab in patients with moderate to severe psoriasis
  publication-title: Pharm Res
  doi: 10.1007/s11095-005-5642-4
– volume: 15
  start-page: 265
  year: 1984
  end-page: 92
  ident: CR42
  article-title: Alternative approaches to estimation of population pharmacokinetic parameters: comparison with the nonlinear mixed-effect model
  publication-title: Drug Metab Rev
  doi: 10.3109/03602538409015066
– volume: 10
  start-page: 56
  year: 2008
  end-page: 69
  ident: CR36
  article-title: Pharmacokinetics of 1, 4-butanediol in rats: bioactivation to gamma-hydroxybutyric acid, interaction with ethanol, and oral bioavailability
  publication-title: AAPS J
  doi: 10.1208/s12248-007-9006-3
– year: 2009
  ident: CR16
  publication-title: NONMEM user’s guides (1989–2009)
– volume: 65
  start-page: 207
  year: 2009
  end-page: 217
  ident: CR29
  article-title: Mechanism-based receptor-binding model to describe the pharmacokinetic and pharmacodynamic of an anti-alpha(5)beta (1) integrin monoclonal antibody (volociximab) in cancer patients
  publication-title: Cancer Chemother Pharmacol
  doi: 10.1007/s00280-009-1023-8
– volume: 39
  start-page: 1
  year: 1977
  end-page: 38
  ident: CR1
  article-title: Maximum likelihood from incomplete data via the EM algorithm
  publication-title: J R Stat Soc B
– volume: 53
  start-page: 46
  year: 2009
  end-page: 56
  ident: CR26
  article-title: Development and qualification of a pharmacodynamic model for the pronounced inoculum effect of ceftazidime against
  publication-title: Antimicrob Agents Chemother
  doi: 10.1128/AAC.00489-08
– ident: CR20
– volume: 326
  start-page: 555
  year: 2008
  ident: 9258_CR38
  publication-title: J Pharmacol Exp Ther
  doi: 10.1124/jpet.108.137703
– volume-title: NONMEM user’s guides (1989–2009)
  year: 2009
  ident: 9258_CR16
– volume: 21
  start-page: 183
  year: 2003
  ident: 9258_CR30
  publication-title: Investig New Drugs
  doi: 10.1023/A:1023573429626
– volume: 9
  start-page: E60
  year: 2007
  ident: 9258_CR4
  publication-title: AAPS J
  doi: 10.1208/aapsj0901007
– volume: 9
  start-page: 635
  year: 1981
  ident: 9258_CR41
  publication-title: J Pharmacokinet Biopharm
  doi: 10.1007/BF01061030
– ident: 9258_CR15
– ident: 9258_CR19
– volume: 4
  start-page: 136
  year: 1983
  ident: 9258_CR50
  publication-title: Siam J Sci Stat Comput
  doi: 10.1137/0904010
– volume: 45
  start-page: 143
  year: 1991
  ident: 9258_CR10
  publication-title: Appl Math Comput
  doi: 10.1016/0096-3003(91)90077-Z
– ident: 9258_CR12
– volume: 15
  start-page: 53
  year: 2005
  ident: 9258_CR44
  publication-title: J Biopharm Stat
  doi: 10.1081/BIP-200040824
– volume: 2
  start-page: E32
  year: 2000
  ident: 9258_CR47
  publication-title: AAPS PharmSci
  doi: 10.1208/ps020332
– volume: 52
  start-page: 934
  year: 1996
  ident: 9258_CR3
  publication-title: Biometrics
  doi: 10.2307/2533054
– volume: 328
  start-page: 644
  year: 2009
  ident: 9258_CR22
  publication-title: J Pharmacol Exp Ther
  doi: 10.1124/jpet.108.144766
– volume: 36
  start-page: 353
  year: 2009
  ident: 9258_CR46
  publication-title: J Pharmacokinet Pharmacodyn
  doi: 10.1007/s10928-009-9126-8
– volume: 34
  start-page: 57
  year: 1998
  ident: 9258_CR9
  publication-title: Clin Pharmacokinet
  doi: 10.2165/00003088-199834010-00003
– volume: 8
  start-page: 553
  year: 1980
  ident: 9258_CR40
  publication-title: J Pharmacokinet Biopharm
  doi: 10.1007/BF01060053
– volume: 15
  start-page: 265
  year: 1984
  ident: 9258_CR42
  publication-title: Drug Metab Rev
  doi: 10.3109/03602538409015066
– volume: 30
  start-page: 185
  year: 2003
  ident: 9258_CR37
  publication-title: J Pharmacokinet Pharmacodyn
  doi: 10.1023/A:1025542026488
– volume: 9
  start-page: 115
  year: 1979
  ident: 9258_CR14
  publication-title: Comput Programs Biomed
  doi: 10.1016/0010-468X(79)90025-4
– volume: 86
  start-page: 290
  year: 2009
  ident: 9258_CR35
  publication-title: Clin Pharmacol Ther
  doi: 10.1038/clpt.2009.87
– volume: 54
  start-page: 2051
  year: 2010
  ident: 9258_CR24
  publication-title: Antimicrob Agents Chemother
  doi: 10.1128/AAC.00881-09
– ident: 9258_CR20
– volume: 46
  start-page: 84
  year: 1992
  ident: 9258_CR17
  publication-title: Am Stat
  doi: 10.2307/2684170
– ident: 9258_CR51
– volume: 28
  start-page: 481
  year: 2001
  ident: 9258_CR39
  publication-title: J Pharmacokinet Pharmacodyn
  doi: 10.1023/A:1012299115260
– volume: 51
  start-page: 6614
  year: 2007
  ident: 9258_CR5
  publication-title: Comput Stat Data Anal
  doi: 10.1016/j.csda.2007.03.008
– start-page: 135
  volume-title: Advanced methods of pharmacokinetic and pharmacodynamic systems analysis
  year: 2003
  ident: 9258_CR18
– ident: 9258_CR13
– year: 2010
  ident: 9258_CR28
  publication-title: Cancer Chemother Pharmacol
  doi: 10.1007/s00280-010-1393-y
– volume: 53
  start-page: 46
  year: 2009
  ident: 9258_CR26
  publication-title: Antimicrob Agents Chemother
  doi: 10.1128/AAC.00489-08
– volume: 8
  start-page: 115
  year: 2004
  ident: 9258_CR53
  publication-title: ESAIM Probab Stat
  doi: 10.1051/ps:2004007
– start-page: 145
  volume-title: Advanced methods of pharmacokinetic and pharmacodynamic systems analysis
  year: 1995
  ident: 9258_CR2
– volume: 39
  start-page: 1
  year: 1977
  ident: 9258_CR1
  publication-title: J R Stat Soc B
  doi: 10.1111/j.2517-6161.1977.tb01600.x
– volume: 22
  start-page: 1088
  year: 2005
  ident: 9258_CR27
  publication-title: Pharm Res
  doi: 10.1007/s11095-005-5642-4
– volume: 11
  start-page: 95
  year: 1983
  ident: 9258_CR6
  publication-title: Ann Stat
  doi: 10.1214/aos/1176346060
– volume: 27
  start-page: 94
  year: 1999
  ident: 9258_CR52
  publication-title: Ann Stat
  doi: 10.1214/aos/1018031103
– volume: 31
  start-page: 299
  year: 2004
  ident: 9258_CR45
  publication-title: J Pharmacokinet Pharmacodyn
  doi: 10.1023/B:JOPA.0000042738.06821.61
– volume: 26
  start-page: 735
  year: 1998
  ident: 9258_CR48
  publication-title: J Pharmacokinet Biopharm
  doi: 10.1023/A:1020707208521
– ident: 9258_CR8
– volume: 48
  start-page: 817
  year: 2009
  ident: 9258_CR33
  publication-title: Clin Pharmacokinet
  doi: 10.2165/11318090-000000000-00000
– volume: 84
  start-page: 111
  year: 2008
  ident: 9258_CR31
  publication-title: Clin Pharmacol Ther
  doi: 10.1038/sj.clpt.6100476
– volume: 73
  start-page: 805
  year: 1978
  ident: 9258_CR11
  publication-title: J Amer Stat Assn
  doi: 10.2307/2286284
– volume: 326
  start-page: 532
  year: 2008
  ident: 9258_CR21
  publication-title: J Pharmacol Exp Ther
  doi: 10.1124/jpet.108.137372
– volume: 52
  start-page: 769
  year: 2008
  ident: 9258_CR34
  publication-title: Toxicon
  doi: 10.1016/j.toxicon.2008.08.013
– volume: 45
  start-page: 365
  year: 2006
  ident: 9258_CR7
  publication-title: Clin Pharmacokinet
  doi: 10.2165/00003088-200645040-00003
– volume: 83
  start-page: 909
  year: 2008
  ident: 9258_CR25
  publication-title: Clin Pharmacol Ther
  doi: 10.1038/clpt.2008.52
– volume: 28
  start-page: 57
  year: 2001
  ident: 9258_CR49
  publication-title: J Pharmacokinet Pharmacodyn
  doi: 10.1023/A:1011517718990
– volume: 334
  start-page: 897
  year: 2010
  ident: 9258_CR23
  publication-title: J Pharmacol Exp Ther
  doi: 10.1124/jpet.110.167304
– volume: 10
  start-page: 56
  year: 2008
  ident: 9258_CR36
  publication-title: AAPS J
  doi: 10.1208/s12248-007-9006-3
– volume: 65
  start-page: 207
  year: 2009
  ident: 9258_CR29
  publication-title: Cancer Chemother Pharmacol
  doi: 10.1007/s00280-009-1023-8
– volume: 63
  start-page: 1049
  year: 2009
  ident: 9258_CR32
  publication-title: Cancer Chemother Pharmacol
  doi: 10.1007/s00280-008-0827-2
– volume: 16
  start-page: 1241
  year: 1997
  ident: 9258_CR43
  publication-title: Stat Med
  doi: 10.1002/(SICI)1097-0258(19970615)16:11<1241::AID-SIM527>3.0.CO;2-C
– reference: 9474473 - Clin Pharmacokinet. 1998 Jan;34(1):57-77
– reference: 18831981 - Toxicon. 2008 Dec 1;52(7):769-80
– reference: 9194270 - Stat Med. 1997 Jun 15;16(11):1241-57; discussion 1257-62
– reference: 11768292 - J Pharmacokinet Pharmacodyn. 2001 Oct;28(5):481-504
– reference: 18446506 - AAPS J. 2008;10(1):56-69
– reference: 18183036 - Clin Pharmacol Ther. 2008 Jul;84(1):111-8
– reference: 19902989 - Clin Pharmacokinet. 2009;48(12):817-26
– reference: 12889739 - Invest New Drugs. 2003 May;21(2):183-94
– reference: 15563005 - J Pharmacokinet Pharmacodyn. 2004 Aug;31(4):299-320
– reference: 19653080 - J Pharmacokinet Pharmacodyn. 2009 Aug;36(4):353-66
– reference: 18388873 - Clin Pharmacol Ther. 2008 Jun;83(6):909-12
– reference: 18791718 - Cancer Chemother Pharmacol. 2009 May;63(6):1049-63
– reference: 20211900 - Antimicrob Agents Chemother. 2010 May;54(5):2051-62
– reference: 20501635 - J Pharmacol Exp Ther. 2010 Sep 1;334(3):897-910
– reference: 17408237 - AAPS J. 2007;9(1):E60-83
– reference: 16028009 - Pharm Res. 2005 Jul;22(7):1088-100
– reference: 15702605 - J Biopharm Stat. 2005;15(1):53-73
– reference: 761456 - Comput Programs Biomed. 1979 Mar;9(2):115-34
– reference: 11741248 - AAPS PharmSci. 2000;2(3):E32
– reference: 19756256 - Comput Stat Data Anal. 2007 Aug 15;51(12):6614-6623
– reference: 16584284 - Clin Pharmacokinet. 2006;45(4):365-83
– reference: 20614121 - Cancer Chemother Pharmacol. 2011 May;67(5):985-94
– reference: 18460643 - J Pharmacol Exp Ther. 2008 Aug;326(2):555-62
– reference: 6745083 - Drug Metab Rev. 1984;15(1-2):265-92
– reference: 7334463 - J Pharmacokinet Biopharm. 1981 Oct;9(5):635-51
– reference: 19516255 - Clin Pharmacol Ther. 2009 Sep;86(3):290-8
– reference: 14571691 - J Pharmacokinet Pharmacodyn. 2003 Jun;30(3):185-219
– reference: 18852268 - Antimicrob Agents Chemother. 2009 Jan;53(1):46-56
– reference: 19468731 - Cancer Chemother Pharmacol. 2010 Jan;65(2):207-17
– reference: 11253614 - J Pharmacokinet Pharmacodyn. 2001 Feb;28(1):57-78
– reference: 1807753 - Proc Annu Symp Comput Appl Med Care. 1991;:922-4
– reference: 10485083 - J Pharmacokinet Biopharm. 1998 Dec;26(6):735-41
– reference: 18448865 - J Pharmacol Exp Ther. 2008 Aug;326(2):532-45
– reference: 18971370 - J Pharmacol Exp Ther. 2009 Feb;328(2):644-51
– reference: 7229908 - J Pharmacokinet Biopharm. 1980 Dec;8(6):553-71
SSID ssj0032311
Score 2.2806053
Snippet The Monte Carlo Parametric Expectation Maximization (MC-PEM) algorithm can approximate the true log-likelihood as precisely as needed and is efficiently...
SourceID unpaywall
pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 212
SubjectTerms Algorithms
Biochemistry
Biomedical and Life Sciences
Biomedicine
Biotechnology
Computer Simulation
Models, Biological
Monte Carlo Method
Pharmaceutical Preparations - administration & dosage
Pharmaceutical Preparations - metabolism
Pharmacokinetics
Pharmacology/Toxicology
Pharmacy
Research Article
SummonAdditionalLinks – databaseName: Unpaywall
  dbid: UNPAY
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9NAEB6V9AAceJeal-aAeqB16vfjaAJVQUpl0UQqJ2vXXrdRXTuKbUH6J_jL7PiREIqKEFd71_Z6v9md2Zn5BuCtT-48jVuqxXVpoKR-qjJhuipPHDu2hOC8yUobnzjHU-vzmX22BaM-F6aJdu9dkm1OA7E05dXhPElbNgTNOyzJH0RBWLrqG7aU2KG8ewe2HVsq5APYnp6EwdeGKdXWVNI5On_mH_tu7kg31Myb0ZIrl-l9uFvnc7b8xrLsl13p6CEk_XjaYJTLYV3xYXz9G9Xjfw74ETzotFYMWpg9hi2RP4G9sKW9Xh7gZJ3FVR7gHoZrQuzlU_gRrrMTkOUJfil4XVa0yGKRolRBcUxfgyO2yAr8dNXYBNT4lFHAe36OQXZeLGbVxRU2MQ4YsgUVgclm1yLBUzX4EIQTlO_A90zCrnkJrXSZ-I5jQcnNDR81UuW3rHwG06OPk9Gx2hWCUGOprVWqa1qWSBKu6UII19FjYQlfmtE6c7hjaczWEkNecOVmm8i_5SQe457jeb7ncV_IRWwHBnmRi11A4RixlZrS6IoNgqcf-xY39Jio9WJueApoPRiiuGNJp2IdWUTWknx41E5FJKcioqmIfAXerbrMW4qQ2xpjj7BICjJ5Z1guirqMPMr6lXJjKPC8BdzqaYZuShBrpgLuBhRXDYgjfPNOPrtouMLNtoKBAvs9xqJukSpv-8j9Fa7_PqQX_9T6Jdxrj-XpIOsVDKpFLV5Lva7ibzq5_QmrbkcB
  priority: 102
  providerName: Unpaywall
Title Performance and Robustness of the Monte Carlo Importance Sampling Algorithm Using Parallelized S-ADAPT for Basic and Complex Mechanistic Models
URI https://link.springer.com/article/10.1208/s12248-011-9258-9
https://www.ncbi.nlm.nih.gov/pubmed/21374103
https://www.proquest.com/docview/864784502
https://pubmed.ncbi.nlm.nih.gov/PMC3085700
https://link.springer.com/content/pdf/10.1208/s12248-011-9258-9.pdf
UnpaywallVersion publishedVersion
Volume 13
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVFSB
  databaseName: Free Full-Text Journals in Chemistry
  customDbUrl:
  eissn: 1550-7416
  dateEnd: 20161231
  omitProxy: true
  ssIdentifier: ssj0032311
  issn: 1550-7416
  databaseCode: HH5
  dateStart: 19990101
  isFulltext: true
  titleUrlDefault: http://abc-chemistry.org/
  providerName: ABC ChemistRy
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 1550-7416
  dateEnd: 20161231
  omitProxy: true
  ssIdentifier: ssj0032311
  issn: 1550-7416
  databaseCode: DIK
  dateStart: 20040101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVFQY
  databaseName: GFMER Free Medical Journals
  customDbUrl:
  eissn: 1550-7416
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0032311
  issn: 1550-7416
  databaseCode: GX1
  dateStart: 20040101
  isFulltext: true
  titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php
  providerName: Geneva Foundation for Medical Education and Research
– providerCode: PRVLSH
  databaseName: SpringerLink Journals
  customDbUrl:
  mediaType: online
  eissn: 1550-7416
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0032311
  issn: 1550-7416
  databaseCode: AFBBN
  dateStart: 19990601
  isFulltext: true
  providerName: Library Specific Holdings
– providerCode: PRVAQN
  databaseName: PubMed Central
  customDbUrl:
  eissn: 1550-7416
  dateEnd: 20161231
  omitProxy: true
  ssIdentifier: ssj0032311
  issn: 1550-7416
  databaseCode: RPM
  dateStart: 20040101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
– providerCode: PRVAVX
  databaseName: SpringerLINK - Czech Republic Consortium
  customDbUrl:
  eissn: 1550-7416
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0032311
  issn: 1550-7416
  databaseCode: AGYKE
  dateStart: 19990101
  isFulltext: true
  titleUrlDefault: http://link.springer.com
  providerName: Springer Nature
– providerCode: PRVAVX
  databaseName: SpringerLink Journals (ICM)
  customDbUrl:
  eissn: 1550-7416
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0032311
  issn: 1550-7416
  databaseCode: U2A
  dateStart: 19990601
  isFulltext: true
  titleUrlDefault: http://www.springerlink.com/journals/
  providerName: Springer Nature
– providerCode: PRVAVX
  databaseName: SpringerLink Journals (ICM)
  customDbUrl:
  eissn: 1550-7416
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0032311
  issn: 1550-7416
  databaseCode: U2A
  dateStart: 19050626
  isFulltext: true
  titleUrlDefault: http://www.springerlink.com/journals/
  providerName: Springer Nature
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9RADB5BewAOiGcJj5UPqAfaiDwmr2MoLQW0VUR3pfYUzUxm25XSpNpkBcuf4C9j57Wsioq4TuaRxB6PPbY_M_Y2IneeJbnJpY0GyiyamUK7gSkz31NcaymbrLTxiX885V_OvLMuj7vqo917l2QjqRsEBCt8X5EPiAKvbDNyPNyld9m2R2heyMRTJ-7Fr4sKi925L_86bPMAuqFV3gyOHDykD9i9ZXEtVt9Fnv9xCB09Yg877RHiltyP2R1dPGG7SQs_vdqHyTqbqtqHXUjWwNSrp-xXss4SAFFk8K2Uy6omYQflDFAVhDGBVcGBWOQlfL5qdHPqfCoo8Ly4gDi_KBfz-vIKmlgDSMSCirHk8586g1Mz_hgnE8A14INA8jeLkMTJ9Q8Ya0oybnChgSqw5dUzNj06nBwcm11BBlOh1lSbgcu5zjJp2VrrwLeV5jpCc9YWvvS5JTwrc7AhwEMvw3_vZ6GQoR-GURjKSKMwec62irLQLxho31F85qLxoxxik0hFXDq2Iog7JZ3QYFZPpVR1aOVUNCNPyWrBydOWsCkSNiXCppHB3g1Drluojts6Q0_6FDcUeUlEoctllYaUfYv86xhsp-WEYTbHdlEBs1yDBRs8MnQgrO7NJ8X8ssHsdttKAgbb67kp7YRFddtL7g0M9-9Pevlfc79i99vrcbpQes226sVSv0H9qpYjth1_Ov96OKJTzhs1uwvbpidJfP4bWuYi3Q
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LU9RAEO7S5YAcfCvx2QeLgxDMYzaPY0RwEZZKSajC09RMMgtbhoTaJKXLn_AvO5PXumJhcU3mkUn39HRPd38N8M5X7jyDE51wUxooE3-iM2G7Ok-cYUyE4LzOShsfOaMT8uV0eNrmcRddtHvnkqwldY2AYHgfCuUDUoFXpu5bQ7lL78IKkfaJNYCV4PO3g91OANtSZTFbB-Y_Oy4fQdf0yuvhkb2PdA1Wq-ySzX-wNP3jGNp7AFG3gCb65Pt2VfLt-OovbMdbrvAh3G_VUgwaPnoEd0T2GDbCBtd6voXRIk2r2MINDBeI1_Mn8CtcpB8gyxL8mvOqKJUUxXyCUsfEsULBwh02S3Pcv6iVftX4mKmI9uwMg_Qsn03L8wusgxgwZDNV5SWdXokEj_XgUxBGKOfAj0zyVT2JEmWp-IljobKXa8BpVKXd0uIpnOztRjsjva30oMdSHSt11yZEJAk3TCGE65ixIMKXdrLJHO4Qgw2NxJIPXHmaJvJPOYnHuOd4nu953BdSSj2DQZZnYh1QOFZMJra0qmJL8Z8f-4RbZqyw82JueRoYHfFp3MKgq2ocKVXmkBycNmSgkgxUkYH6Grzvu1w2GCA3NcaOo6jcqcr9wjKRVwX1VFqv3BiWBs8bButHs0xbanaGrYG7xHp9AwUCvvwmm57XYOB2U6JAg82Op2grhYqbPnKz5-P_L-nFrcZ-C6ujaHxID_ePDl7CveYOXt1avYJBOavEa6nElfxNu2l_Az5dPm0
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Zb9NAEF5BkTgeEFfBnPOA-kBr1cfGsR9NS9QCqSyaSH1b7drrNpJrR7GjNvwJ_jIzvkJUVMSrvYe9Mzs7szPzDWMfA3LnWYqbXNlooKRBakrtDk2VeIOYa61UnZU2PvGOpvzr2eCsrXNadtHunUuyyWkglKa82p8naYOGYPn7JfmDKAjLNgNngDv2LrvHCScBGXrqhJ0odlF5sVtX5l-7bR5GNzTMm4GSvbf0EXuwzOdydSWz7I8DafSEPW41SQgb0j9ld3T-jO1EDRT1ag8m68yqcg92IFqDVK-es1_ROmMAZJ7Aj0Ity4oEHxQpoFoIY1oSOJCLrIDjy1pPp8ankoLQ83MIs_NiMasuLqGOO4BILqgwSzb7qRM4NcPDMJoAzgGfJbJCPQlJn0xfw1hTwnGNEQ1UjS0rX7Dp6Mvk4MhsizOYMWpQlTl0OddJoixbaz307FhzHaBpa0tPedySAytx8MEQD8AE195LfKl8z_cD31eBRsGyzbbyItevGGjPiXnqoiEUO8QyQRxw5dgxwd3FyvENZnVUEnGLXE4FNDJBFgwOLhrCCiSsIMKKwGCf-i7zBrbjtsbQkV7g5iKPicx1sSyFT5m4yMuOwV42nNCP5tguKmOWa7DhBo_0DQi3e_NNPruo8bvdpqqAwXY7bhKt4Chv-8jdnuH-_Uuv_2vsD-x-dDgS349Pvr1hD5tbc7pnesu2qsVSv0O1q1Lv6631G0s5Jds
linkToUnpaywall http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9NAEB6V9AAceJeal-aAeqB16vfjaAJVQUpl0UQqJ2vXXrdRXTuKbUH6J_jL7PiREIqKEFd71_Z6v9md2Zn5BuCtT-48jVuqxXVpoKR-qjJhuipPHDu2hOC8yUobnzjHU-vzmX22BaM-F6aJdu9dkm1OA7E05dXhPElbNgTNOyzJH0RBWLrqG7aU2KG8ewe2HVsq5APYnp6EwdeGKdXWVNI5On_mH_tu7kg31Myb0ZIrl-l9uFvnc7b8xrLsl13p6CEk_XjaYJTLYV3xYXz9G9Xjfw74ETzotFYMWpg9hi2RP4G9sKW9Xh7gZJ3FVR7gHoZrQuzlU_gRrrMTkOUJfil4XVa0yGKRolRBcUxfgyO2yAr8dNXYBNT4lFHAe36OQXZeLGbVxRU2MQ4YsgUVgclm1yLBUzX4EIQTlO_A90zCrnkJrXSZ-I5jQcnNDR81UuW3rHwG06OPk9Gx2hWCUGOprVWqa1qWSBKu6UII19FjYQlfmtE6c7hjaczWEkNecOVmm8i_5SQe457jeb7ncV_IRWwHBnmRi11A4RixlZrS6IoNgqcf-xY39Jio9WJueApoPRiiuGNJp2IdWUTWknx41E5FJKcioqmIfAXerbrMW4qQ2xpjj7BICjJ5Z1guirqMPMr6lXJjKPC8BdzqaYZuShBrpgLuBhRXDYgjfPNOPrtouMLNtoKBAvs9xqJukSpv-8j9Fa7_PqQX_9T6Jdxrj-XpIOsVDKpFLV5Lva7ibzq5_QmrbkcB
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Performance+and+Robustness+of+the+Monte+Carlo+Importance+Sampling+Algorithm+Using+Parallelized+S-ADAPT+for+Basic+and+Complex+Mechanistic+Models&rft.jtitle=The+AAPS+journal&rft.au=Bulitta%2C+Jurgen+B.&rft.au=Landersdorfer%2C+Cornelia+B.&rft.date=2011-06-01&rft.pub=Springer+US&rft.eissn=1550-7416&rft.volume=13&rft.issue=2&rft.spage=212&rft.epage=226&rft_id=info:doi/10.1208%2Fs12248-011-9258-9&rft_id=info%3Apmid%2F21374103&rft.externalDocID=PMC3085700
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1550-7416&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1550-7416&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1550-7416&client=summon